Experimental Radioprotective Drug Safe for Lung Cancer Patients: University of Pittsburgh Cancer Institute (UPCI) Study

Published: Mar 22, 2011

Physorg.com -- Patients with advanced non-small cell lung cancer can safely take an experimental oral drug intended to protect healthy tissue from the effects of radiation, according to a study led by researchers at the University of Pittsburgh Cancer Institute (UPCI) and published in this month's issue of Human Gene Therapy.

Back to news